VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares traded down 10.5% during mid-day trading on Tuesday . The company traded as low as C$0.09 and last traded at C$0.09. 138,064 shares changed hands during trading, a decline of 17% from the average session volume of 167,064 shares. The stock had previously closed at C$0.10.
VentriPoint Diagnostics Stock Down 10.5%
The company has a current ratio of 0.28, a quick ratio of 6.67 and a debt-to-equity ratio of -58.56. The company has a 50-day simple moving average of C$0.10 and a 200 day simple moving average of C$0.12. The company has a market cap of C$14.17 million, a P/E ratio of -4.25 and a beta of -0.53.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Further Reading
- Five stocks we like better than VentriPoint Diagnostics
- Industrial Products Stocks Investing
- Stellantis Makes a High-Stakes Bet on Jeep
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Nuclear Energy Earnings: Which Names Won and Lost in Q3
- What is a Dividend King?
- Alphabet: Buffett’s Bet on Its Next Phase of Growth
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
